This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, D.-B. Articles by DeLuca, N. A. Search for Related Content PubMed PubMed Citation Articles by Kim, D.-B. Articles by DeLuca, N. A.

Phosphorylation of Transcription Factor Sp1 during Herpes Simplex Virus Type 1 Infection

Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Received 29 January 2002/ Accepted 8 April 2002

The expression of most herpes simplex virus type 1 (HSV-1) immediate-early (IE) and early (E) genes decreases late in productive infection. IE and E promoters contain various binding sites for cellular activators, including sites for Sp1, upstream of the TATA box, while late gene promoters generally lack such sites. To address the possibility that Sp1 function may be altered during the course of infection, the modification state and activity of Sp1 were investigated as a function of infection. Sp1 was quantitatively phosphorylated in HSV-1-infected cells without a significant change in abundance. The kinetics of accumulation of phosphorylated Sp1 immediately preceded the decline in E gene (thymidine kinase gene [tk]) mRNA abundance. Phosphorylation of Sp1 required ICP4; however, the proportion of phosphorylated Sp1 was reduced during infection in the presence of phosphonoacetic acid or in the absence of ICP27. While the DNA binding activity of Sp1 was not greatly affected by phosphorylation, the ability of phosphorylated Sp1 isolated from HSV-infected cells to activate transcription in vitro was decreased. These studies suggest that modification of Sp1 may contribute to the decrease of IE and E gene expression late in infection.

This article has been cited by other articles:

• Olofsson, B. A., Kelly, C. M., Kim, J., Hornsby, S. M., Azizkhan-Clifford, J. (2007). Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase. Mol Cancer Res 5: 1319-1330 [Abstract] [Full Text]  
• Iwahori, S., Shirata, N., Kawaguchi, Y., Weller, S. K., Sato, Y., Kudoh, A., Nakayama, S., Isomura, H., Tsurumi, T. (2007). Enhanced Phosphorylation of Transcription Factor Sp1 in Response to Herpes Simplex Virus Type 1 Infection Is Dependent on the Ataxia Telangiectasia-Mutated Protein. J. Virol. 81: 9653-9664 [Abstract] [Full Text]  
• Hamza, M. S., Reyes, R. A., Izumiya, Y., Wisdom, R., Kung, H.-J., Luciw, P. A. (2004). ORF36 Protein Kinase of Kaposi's Sarcoma Herpesvirus Activates the c-Jun N-terminal Kinase Signaling Pathway. J. Biol. Chem. 279: 38325-38330 [Abstract] [Full Text]  
• Zabierowski, S., DeLuca, N. A. (2004). Differential Cellular Requirements for Activation of Herpes Simplex Virus Type 1 Early (tk) and Late (gC) Promoters by ICP4. J. Virol. 78: 6162-6170 [Abstract] [Full Text]  
• Advani, S. J., Durand, L. O., Weichselbaum, R. R., Roizman, B. (2003). Oct-1 Is Posttranslationally Modified and Exhibits Reduced Capacity To Bind Cognate Sites at Late Times after Infection with Herpes Simplex Virus 1. J. Virol. 77: 11927-11932 [Abstract] [Full Text]  
• Peng, H., He, H., Hay, J., Ruyechan, W. T. (2003). Interaction between the Varicella Zoster Virus IE62 Major Transactivator and Cellular Transcription Factor Sp1. J. Biol. Chem. 278: 38068-38075 [Abstract] [Full Text]